Viewing Study NCT02120469


Ignite Creation Date: 2025-12-24 @ 10:57 PM
Ignite Modification Date: 2026-03-13 @ 11:55 AM
Study NCT ID: NCT02120469
Status: COMPLETED
Last Update Posted: 2022-07-05
First Post: 2014-04-18
Is Gene Therapy: True
Has Adverse Events: True

Brief Title: Eribulin Mesylate and Everolimus in Treating Patients With Triple-Negative Metastatic Breast Cancer
Sponsor: City of Hope Medical Center
Organization:

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Estrogen Receptor Negative View
None HER2/Neu Negative View
None Progesterone Receptor-negative View
None Stage IV Breast Cancer View
None Triple-negative Breast Carcinoma View
Keywords: